Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SC0032 oral spray for refractory or unexplained chronic cough
ISRCTN56616986Phase 2Recruiting
- Sponsor
- Sensory Cloud
- Start
- Mar 2026
- Modality
- Small Molecules
01
Overview
Phase 2, randomised trial in refractory chronic cough (RCC) and chronic idiopathic cough (CIC) comparing SC0032 with Placebo (2 arms). Started Mar 2026; status: recruiting.
02
Drugs
SC0032
03
Conditions
refractory chronic cough (RCC)chronic idiopathic cough (CIC)
Beyond the preview
Go deeper on ISRCTN56616986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN56616986.